Epigenetic modulation in obsessive-compulsive disorder: Methylation and hydroxymethylation of the bdnf gene exon I promoter

  • Vanzetto S
  • Alberto V
  • Conti D
  • et al.
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

analyses will address a Linear Discriminant Analysis to proceed to a machine learning oriented approach. Disclosure: No significant relationships. Introduction: Several evidence recognizes Brain Derived Neuro-trophic Factor (BDNF) as a promising biomarker in the patho-physiology of psychiatric disorders, including Obsessive-Compulsive Disorder (OCD), considering the involvement of epi-genetic regulation in BDNF altered expression. Objectives: This study aims to investigate, in a sample of OCD patients, the epigenetic modulation in terms of levels of methyla-tion and hydroxymethylation on the BDNF gene exon I promoter. Methods: Fifty OCD patients, recruited from Psychiatry Unit 2, Sacco University Hospital in Milan and fifty healthy controls, comparable by age and gender. Saliva samples were collected by oral swab and epigenetic analysis were performed at the University of Teramo. Statistical analyses were performed with t test with Bonferroni correction. Results: Data analysis showed a significant decrease in 5-methyl cytosine levels (5mC) (mean OCD: 1.221%; mean CTRL: 1.784%; p < 0.001) and a significant increase in 5-Hydroxy-methyl cytosine levels (5hmC) (mean OCD: 1.018%; mean CTRL: 0.527% p< 0.0001) in BDNF gene exon I promoter of OCD patients compared to controls. Regarding 5mC of site 3 and 5hmC of site 1 and 2 of the exon I promoter CpG islands, no statistical significance was found. Conclusions: Present results showed significant differences in epi-genetic modulation of BDNF gene, which might not be univocally interpreted. They could represent an intrinsic OCD characteristic or the effect of antidepressant drugs, assumed by all recruited patients. Further studies, comparing OCD subjects in treatment vs drug-free, are necessary to define BDNF epigenetic modulation role and its possible use as biomarker in the characterization of OCD. Disclosure: No significant relationships.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Vanzetto, S., Alberto, V., Conti, D., Macellaro, M., Benatti, B., Daddario, C., … Dell’Osso, B. (2021). Epigenetic modulation in obsessive-compulsive disorder: Methylation and hydroxymethylation of the bdnf gene exon I promoter. European Psychiatry, 64(S1), S124–S124. https://doi.org/10.1192/j.eurpsy.2021.348

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 2

67%

Researcher 1

33%

Readers' Discipline

Tooltip

Medicine and Dentistry 2

67%

Psychology 1

33%

Save time finding and organizing research with Mendeley

Sign up for free